• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

The BA.5 variant is spreading, and your COVID immunity might be gone because of it.

by William Jester | Jul 18, 2022 | Community, Covid, News

It’s the most infectious strain yet, coming even as many people have written off the pandemic. BA.5, now the dominant coronavirus subvariant in New Jersey and the U.S., has shown resistance to COVID-19 vaccines, making experts nervous. Worse, prior immunity doesn’t...

Some Pre-existing Mutant Strains of the Virus Causing COVID-19 May Resist Paxlovid.

by William Jester | Jul 15, 2022 | Community, Covid, News

Researchers from Rutgers, the University of South Florida and Catholic University of America, whose work has yet to undergo peer review, identified 66 prevalent Mpro mutations located at the nirmatrelvir binding site, where Paxlovid attaches itself to the virus. Many...

NJACTS Community Engagement Core COVID-19 Resources

by William Jester | Jul 15, 2022 | Community, Covid, News

The situation around the current spread of COVID-19 is changing rapidly. We have compiled resource links for the general community highlighting local resources across New Jersey, ways to get involved, and mental and physical wellness. Visit our COVID-19 page for...

Using Artificial Intelligence and Innovative Design to Save Patient’s Lives During the COVID19 Pandemic.

by William Jester | Jul 5, 2022 | Community, Covid, News

SARS-CoV-2 infection may lead to Coronavirus Disease 19 (COVID19), which can severely hamper the function of a patient’s lungs and require that the patient utilize a medical device to help them respirate. One such device to help patients effectively respirate is a...

NJ employers: What do we have to do to get you back in the office?

by William Jester | Jul 1, 2022 | Community, Covid, News

When it is finished, CentralReach’s office will have all the amenities you would expect from a high-tech company: moveable furniture, whiteboards, televisions, a kitchen, all to bring out the best in its work force. The big question: Will the office have...
« Older Entries
Next Entries »

Recent Posts

  • Grant Writing Mini Course – Registration Deadline Today!
  • New Jersey coasts, lined with toxic facilities, don’t fare well in two new studies.
  • Translational Science Competency-Based Assessment Pilot Test Sign Up
  • As few as 2 cigarettes per day linked to 50% increased risk of heart disease: Study
  • What You Need to Know About ‘Ozempic Face,’ According to Doctors.

Archives

  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,404)
  • Covid (993)
  • CTO Events (6)
  • News (3,046)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.